Sanomedics Signs Comprehensive Distribution Agreement With Alliant Healthcare Products

MIAMI, Feb. 24, 2015 (GLOBE NEWSWIRE) -- Sanomedics, Inc. (OTCBB:SIMH) ("Sanomedics" or the "Company"), a medical technology company that focuses on providing game changing products, services and ideas, announced today that the Company's Thermomedics, Inc. division, makers of the world's leading TouchFreeTM Clinical Thermometer, Caregiver®, has signed a comprehensive distribution agreement with Alliant Healthcare Products, a leading distributor of healthcare products to federal supply channels.

Alliant Healthcare Products is a service-disabled, veteran-owned small business which has been awarded over $380 million in government sales contracts since 2010 to every Veterans Affairs (VA) and Department of Defense (DoD) facility worldwide. The agreement with Thermomedics is focused on the proactive selling of all Thermomedics' products including the Caregiver, into the federal government and identifying new opportunities.

"The ability to successfully penetrate federal supply channels and government agencies has been a key growth area for Thermomedics and with the signing of Alliant Healthcare Products, we've found a strategic partner with industry expertise, contacts and un-paralleled market understanding," said Keith Houlihan, President and founder of Sanomedics. "Alliant has a knowledgeable sales team and key relationships with the administrators that manage the 281 VA and DoD hospitals in the U.S. We are confident that this distribution agreement will increase awareness and use of the Caregiver in federal agencies."

"The popularity and use of the Caregiver at hospitals, medical centers and even at our nation's airports continues to grow as medical professionals and personnel work to instill appropriate infectious disease prevention protocols," said Ron Benincasa, VP Sales and Marketing for Thermomedics. "Our Caregiver thermometer provides medical professionals, especially in urgent situations treating highly infectious diseases such as Ebola, Flu, and other Viral and Bacterial entities, with a touch free device that will help minimize contact and enhance infection control."

About Sanomedics, Inc.

Sanomedics, Inc. (SIMH) is a medical technology company that focuses on game changing products, services and ideas -- a place where physicians, entrepreneurs, and medical companies can work together to drive innovative technologies through concept, development, and ultimately commercialization. Sanomedics plans to grow existing business organically and through strategic acquisitions specifically relating to healthcare technology and services.

About Alliant Healthcare Products

Alliant Healthcare Products which was founded in 2002, has been awarded over $380M in government sales contracts since 2010 to every VA and DoD facility worldwide. As a Service-Disabled, Veteran-Owned Small Business (SDVOSB), Alliant has a tremendous competitive selling advantage within the federal space. The team of government contracting experts is able to navigate federal facilities and build lasting relationships with key buying personnel. Alliant's sales resources include a Field Sales Team as well as an Inside Sales Team, who make sure all sales opportunities are given the attention to detail required to close government business. Alliant Healthcare partners with some of the largest and most respected healthcare product providers in the world such as Philips, Olympus, Skytron, and many others.

Forward Looking Statements

Statements in this press release regarding Sanomedics that are not historical facts are forward- looking statements and are subject to risks and uncertainties that could cause actual future events or results to differ materially from such statements. Any such forward-looking statements, including, but not limited to, financial guidance are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not directly or exclusively relate to historical facts. In some cases, you can identify forward-looking statements by terms such as "may," "will," "should," "could," "would," "expects," "plans," "anticipates," "believes," "estimates," "projects," "forecasts," "predicts," "potential," or the negative of those terms, and similar expressions and comparable terminology. These include, but are not limited to, statements relating to future events or our future financial and operating results, plans, objectives, expectations and intentions. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these expectations may not be achieved. Forward-looking statements represent our intentions, plans, expectations, assumptions and beliefs about future events and are subject to known and unknown risks, uncertainties and other factors outside of our control that could cause our actual results, performance or achievement to differ materially from those expressed or implied by these forward-looking statements.

These forward-looking statements represent our estimates and assumptions only as of the date of this release and, except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise after the date of this release. Given these uncertainties, you should not place undue reliance on these forward-looking statements and should consider various factors, including the risks described, among other places, in our most recent Annual Report on Form 10-K and in our Quarterly Reports on Form 10-Q, as well as any amendments thereto, filed with the SEC.

CONTACT: Investor Contacts: Phil Carlson / Thomas Mei KCSA Strategic Communications 212-896-1233 / 212-896-1208 / Media Contacts: Chloe Font / Andrew Herweg KCSA Strategic Communications 212-896-1287 / 212-896-1273 /

Source:Sanomedics International Holdings, Inc.